Show simple item record

dc.contributor.authorFuenmayor, Evert
dc.contributor.authorForde, Martin
dc.contributor.authorHealy, Andrew M.
dc.contributor.authorDevine, Declan M.
dc.contributor.authorLyons, John G.
dc.contributor.authorMcConville, Christopher
dc.contributor.authorMajor, Ian
dc.date.accessioned2020-01-23T15:01:34Z
dc.date.available2020-01-23T15:01:34Z
dc.date.copyright2018
dc.date.issued2018-04-02
dc.identifier.citationFuenmayor, E., Forde, M., Healy, A.V., Devine, D. M., Lyons, J.G., McConville, C., Major, I. (2018). Material considerations for fused-filament fabrication of solid dosage forms. Pharmaceutics. 10(2), pii: E44. doi: 10.3390/pharmaceutics10020044.en_US
dc.identifier.issn1999-4923
dc.identifier.issn1999-4923
dc.identifier.otherMaterials Research Institute AIT - Articlesen_US
dc.identifier.urihttp://research.thea.ie/handle/20.500.12065/2962
dc.description.abstractMaterial choice is a fundamental consideration when it comes to designing a solid dosage form. The matrix material will ultimately determine the rate of drug release since the physical properties (solubility, viscosity, and more) of the material control both fluid ingress and disintegration of the dosage form. The bulk properties (powder flow, concentration, and more) of the material should also be considered since these properties will influence the ability of the material to be successfully manufactured. Furthermore, there is a limited number of approved materials for the production of solid dosage forms. The present study details the complications that can arise when adopting pharmaceutical grade polymers for fused-filament fabrication in the production of oral tablets. The paper also presents ways to overcome each issue. Fused-filament fabrication is a hot-melt extrusion-based 3D printing process. The paper describes the problems encountered in fused-filament fabrication with Kollidon® VA64, which is a material that has previously been utilized in direct compression and hot-melt extrusion processes. Formulation and melt-blending strategies were employed to increase the printability of the material. The paper defines for the first time the essential parameter profile required for successful 3D printing and lists several pre-screening tools that should be employed to guide future material formulation for the fused-filament fabrication of solid dosage forms.en_US
dc.formatPDFen_US
dc.language.isoenen_US
dc.publisherMDPIen_US
dc.relation.ispartofPharmaceuticsen_US
dc.rightsAttribution-NonCommercial-NoDerivs 3.0 Ireland*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/3.0/ie/*
dc.subject3D printingen_US
dc.subjectFused-filament fabricationen_US
dc.subjectAdditive manufacturingen_US
dc.subjectHot-melt extrusionen_US
dc.subjectFormulationen_US
dc.subjectMelt-blendingen_US
dc.subjectSolid dosage formsen_US
dc.subjectTabletsen_US
dc.titleMaterial considerations for fused-filament fabrication of solid dosage forms.en_US
dc.typeArticleen_US
dc.description.peerreviewyesen_US
dc.identifier.doidoi: 10.3390/pharmaceutics10020044.
dc.identifier.orcidhttps://orcid.org/0000-0001-8982-7845
dc.identifier.orcidhttps://orcid.org/0000-0002-1364-5583
dc.identifier.orcidhttps://orcid.org/0000-0002-2610-2975
dc.identifier.orcidhttps://orcid.org/0000-0002-1364-5583
dc.identifier.orcidhttps://orcid.org/0000-0003-1998-070X
dc.identifier.orcidhttps://orcid.org/0000-0002-0538-9786
dc.rights.accessOpen Accessen_US
dc.subject.departmentMaterials Research Institute - AITen_US


Files in this item

Thumbnail
Thumbnail

This item appears in the following Collection(s)

Show simple item record

Attribution-NonCommercial-NoDerivs 3.0 Ireland
Except where otherwise noted, this item's license is described as Attribution-NonCommercial-NoDerivs 3.0 Ireland